Syndax Pharmaceuticals SNDX Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's cash provided by (used in) investing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's cash provided by (used in) investing activity, including discontinued operation?
- Syndax Pharmaceuticals (SNDX) reported cash provided by (used in) investing activity, including discontinued operation of $38.39M in Q1 2026.
- How has Syndax Pharmaceuticals's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- Syndax Pharmaceuticals's cash provided by (used in) investing activity, including discontinued operation decreased by 59.2% year-over-year, from $94.14M to $38.39M.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.